UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 163 filers reported holding UNIQURE NV in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2 | -33.3% | 268 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $3 | -82.4% | 268 | -67.9% | 0.00% | -75.0% |
| Q1 2023 | $17 | -10.5% | 834 | 0.0% | 0.00% | -33.3% |
| Q4 2022 | $19 | -99.9% | 834 | +9.3% | 0.01% | +50.0% |
| Q3 2022 | $14,000 | -12.5% | 763 | -8.5% | 0.00% | 0.0% |
| Q2 2022 | $16,000 | +6.7% | 834 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $15,000 | -16.7% | 834 | +904.8% | 0.00% | 0.0% |
| Q4 2021 | $18,000 | +38.5% | 83 | -79.0% | 0.00% | -33.3% |
| Q2 2021 | $13,000 | 0.0% | 395 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $13,000 | +550.0% | 395 | +758.7% | 0.01% | +500.0% |
| Q4 2020 | $2,000 | – | 46 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |